Inari Medical Inc.
79.25
-0.06%
At close: Jan 10, 2025, 3:58 PM
79.42
0.21%
After-hours Jan 10, 2025, 04:38 PM EST
undefined%
Bid 79.17
Market Cap 4.64B
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -1.35
PE Ratio (ttm) -58.7
Forward PE n/a
Analyst Hold
Ask 79.47
Volume 11,097,635
Avg. Volume (20D) 1,703,690
Open 79.35
Previous Close 79.30
Day's Range 79.16 - 79.44
52-Week Range 36.73 - 79.69
Beta undefined

About NARI

Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombecto...

Sector Healthcare
IPO Date May 22, 2020
Employees 1,300
Stock Exchange NASDAQ
Ticker Symbol NARI

Analyst Forecast

According to 12 analyst ratings, the average rating for NARI stock is "Hold." The 12-month stock price forecast is $75, which is a decrease of -5.36% from the latest price.

Buy 16.67%
Hold 83.33%
Sell 0.00%
Stock Forecasts

Next Earnings Release

Inari Medical Inc. is scheduled to release its earnings on Feb 26, 2025, during market hours.
Analysts project revenue of $160.61M, reflecting a 21.59% YoY growth and earnings per share of -0.03, making a -62.50% decrease YoY.

Past Earnings Volatility

The average price volatility over this 3-day period is ... Unlock content with Pro Subscription
5 days ago · Source
+22.23%
Inari Medical shares are trading higher after Stry... Unlock content with Pro Subscription
5 days ago · Source
+30.6%
Inari Medical shares are trading higher following a Reuters report suggesting Stryker is nearing a deal to acquire the company.